881 studies found for:    "Sexually Transmitted Diseases, Viral"
Show Display Options
RSS Create an RSS feed from your search for:
"Sexually Transmitted Diseases, Viral"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed Group Therapies for Reducing HIV-risk Behavior in Women Who Have Survived Childhood Sexual Abuse
Conditions: Alcoholism;   Child Abuse, Sexual;   Sexual Abuse;   Sexual Behavior;   Sexually Transmitted Diseases, Viral
Intervention: Behavioral: Trauma-focused group therapy
2 Completed Measuring Responses to Sublingual Antigens
Condition: Sexually Transmitted Diseases, Viral
Intervention: Biological: Human Papillomavirus 6,11,16,18 Vaccine Recombinant alum ads
3 Completed HIV Prevention Intervention for Couples
Condition: Acquired Immunodeficiency Syndrome
Interventions: Behavioral: Couples HIV counseling and testing;   Behavioral: Women's relationship-focused HIV counseling and testing
4 Completed Physician Focused Intervention to Improve Adherence With HIV Antiretrovirals
Conditions: HIV Infection;   HIV Infections
Intervention: Behavioral: Adherence report
5 Completed A Safety Study Of A Single Vaginal Administration Of P2G12 Antibody In Healthy Female Subjects
Condition: Human Immunodeficiency Virus
Intervention: Drug: P2G12
6 Active, not recruiting
Has Results
Study Assessing Dolutegravir in HIV-1 Infected Subjects With Virus Resistant to Raltegravir and/or Elivitegravir
Condition: Infection, Human Immunodeficiency Virus
Interventions: Drug: dolutegravir 50 mg twice daily;   Drug: dolutegravir placebo twice daily;   Drug: Open-label dolutegravir 50mg twice daily
7 Recruiting Cause of Focal Segmental Glomerulosclerosis
Conditions: AIDS Associated Nephropathy;   Focal Glomerulosclerosis;   HIV Infections
Intervention:
8 Not yet recruiting Open-label Study of Dolutegravir (DTG) or Efavirenz (EFV) for Human Immunodeficiency Virus (HIV) - Tuberculosis (TB) Co-infection
Condition: Infection, Human Immunodeficiency Virus
Interventions: Drug: DTG 50 mg;   Drug: EFV 600 mg
9 Terminated Safety and Tolerability of Z-100 in Patients With Early HIV Infection
Condition: HIV Infections
Intervention: Drug: Z-100
10 Completed A Study of Two Forms of Pentamidine in the Treatment of Pneumocystis Carinii Pneumonia (PCP) in Patients With AIDS
Conditions: Pneumonia, Pneumocystis Carinii;   HIV Infections
Intervention: Drug: Pentamidine isethionate
11 Completed A Study of Itraconazole in Preventing the Return of Histoplasmosis, a Fungal Infection, in Patients With AIDS
Conditions: HIV Infections;   Histoplasmosis
Intervention: Drug: Itraconazole
12 Not yet recruiting The Effects of Statin Therapy on Coronary Flow Reserve and Inflammatory Markers in HIV-Positive Patients
Conditions: Human Immunodeficiency Virus (HIV);   Cardiovascular Disease (CVD)
Intervention: Drug: Rosuvastatin
13 Completed A Study to Evaluate the Effect of Cimetidine on CD4 Lymphocyte Counts in HIV Infection
Condition: HIV Infections
Intervention: Drug: Cimetidine
14 Completed Phase I Rising Dose Tolerability Study of SC-48334 in Patients With Acquired Immunodeficiency Syndrome (AIDS) and Advanced AIDS Related Complex
Condition: HIV Infections
Intervention: Drug: Butyldeoxynojirimycin
15 Recruiting Exploring Novel Mechanisms of Vaccine Failure LAIV Pilot Study
Condition: Acquired Immune Deficiency Syndrome Virus
Intervention: Biological: Live attenuated Vaccine- Fluenz Tretra
16 Completed Leukapheresis to Obtain Lymphocytes for Studies on Antiretroviral Naive HIV-infected Patients
Condition: Human Immunodeficiency Virus
Intervention: Procedure: leukapheresis
17 Active, not recruiting Prospective Observational Epidemiologic Study of Maraviroc's Safety
Condition: Human Immunodeficiency Virus
Interventions: Drug: Maraviroc along with an optimized background antiretroviral drug regimen;   Drug: Optimized background antiretroviral drug regimen without maraviroc
18 Recruiting Opioid Relapse & HIV Risk: 48 Versus 24 Weeks of Injectable Extended Release Naltrexone
Conditions: Opiate Dependence;   Human Immunodeficiency Virus
Interventions: Drug: injectable naltrexone;   Drug: placebo comparator
19 Completed Efficacy of HIV Post-Test Support for ANC in South Africa
Conditions: HIV;   Acquired Immunodeficiency Syndrome
Interventions: Behavioral: Enhanced Counseling;   Behavioral: Standard of Care
20 Completed Immune Response to a Therapeutic HIV Vaccine Followed by Treatment Interruption in Patients With Acute or Recent HIV Infection
Condition: HIV Infections
Interventions: Biological: MRKAd5 HIV-1 gag/pol/nef;   Biological: MRKAd5 HIV-1 gag/pol/nef placebo

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years